Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3 Sarcoma 1 Other solid neoplasm 1 Genitourinary 1

Conditions

Prostate Cancer Recurrent 1

Interventions

pembrolizumab 75 Injections 67 Carboplatin 38 Pemetrexed 29 Cisplatin 29 Nivolumab 27 Specimen Handling 24 Interviews as Topic 24 Cyclophosphamide 24 atezolizumab 21 tislelizumab 20 Bevacizumab 20 Paclitaxel 19 Standard of Care 16 Practice Guidelines as Topic 16 fludarabine 15 Docetaxel 15 toripalimab 14 Ipilimumab 14 Educational Status 14 Cetuximab 14 Fluorouracil 13 Oxaliplatin 12 Etoposide 12 olaparib 11 durvalumab 11 Methods 11 Gemcitabine 11 Early Intervention, Educational 11 Drug Therapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Nelfinavir × Other solid neoplasm × 1 year × Clear all

NCT05036226 2026-05-13

COAST

Medical University of South Carolina

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡